Bookmark

Add to MyYahoo RSS

AstraZeneca News

News on AstraZeneca (Ticker: AZN) continually updated from thousands of sources around the net.

6 hrs ago | Seeking Alpha

Competition And Momentum Weighing On Clovis Oncology

Analysts and investors have started fretting that AstraZeneca's drug will be a stronger potential rival to Clovis's lead drug rociletinib.

Comment?

Related Topix: Biotech, Medicine, AstraZeneca Group, Healthcare Industry, Oncology, Diabetes, Health

Fri Aug 22, 2014

AmericanBankingNews.com

Panmure Gordon Reiterates Hold Rating for AstraZeneca plc

AstraZeneca plc traded down 0.19% during mid-day trading on Friday, hitting $73.05.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, AstraZeneca Group

Thu Aug 21, 2014

Seeking Alpha

Nektar Therapeutics Has More To Give

Investors should know within a month whether the FDA will approve Movantik, Nektar's opioid-induced constipation drug partnered with AstraZeneca that has $1B+ potential.

Comment?

Related Topix: Startups, Nektar Therapeutics, Healthcare Law, Law, Medicine, Constipation, Health, Biotech, AstraZeneca Group, Healthcare Industry, Oncology

BioSpace

Pfizer Inc. Eyes Possible Actavis Bid Whilst Weighing Next Steps Over AstraZeneca PLC

Pfizer Inc. isn't giving up on striking an overseas takeover to cut its tax rate and gain a new pipeline of drugs, even as the potential cost of acquiring AstraZeneca Plc rises.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, AstraZeneca Group

TheStreet.com

Why AstraZeneca (AZN) Stock Is Higher Today

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Biotech, Medicine, AstraZeneca Group, Healthcare Industry, Mozilla, Financial Markets

AmericanBankingNews.com

AstraZeneca plc Receives "Hold" Rating from Beaufort Securities

AstraZeneca plc opened at 4375.50 on Thursday. AstraZeneca plc has a 52 week low of GBX 3086.50 and a 52 week high of GBX 5750.00.

Comment?

Related Topix: Biotech, Medicine, AstraZeneca Group, Healthcare Industry

Customer Interaction Solutions

Illumina Announces Strategic Partnerships with AstraZeneca, Janssen...

The system will be used for clinical trials of targeted cancer therapies with a goal of developing and commercializing a multi-gene panel for therapeutic selection, resulting in a more comprehensive tool for precision medicine.

Comment?

Related Topix: Scientific Instruments, Biotech, Illumina, Medicine, Healthcare Industry, AstraZeneca Group, Oncology

Wed Aug 20, 2014

BioSpace

AstraZeneca PLC, Mitsubishi Tanabe Pharma Corporation Link Up For Diabetes Research

AstraZeneca and Mitsubishi Tanabe Pharma said on Wednesday they said signed a three-year research collaboration into diabetic nephropathy, or kidney failure due to diabetes.

Comment?

Related Topix: Biotech, Medicine, Health, Healthcare Industry, Diabetes, AstraZeneca Group

Tue Aug 19, 2014

WJRT

The Zacks Analyst Blog Highlights: Tesla Motors, CarMax, O'Reilly...

Information contained on this page is provided by an independent third-party content provider.

Comment?

Related Topix: Auto Dealers, Retail, CarMax Group, Tesla Motors, Startups, Financial Markets, OReilly Automotive, Auto Parts, Biotech, Medicine, AstraZeneca Group, Healthcare Industry

TheStreet.com

How Will AstraZeneca (AZN) Stock Respond To U.S. Clearing Heart Drug Trial?

The company said the government was closing its investigation into the 18,000-patient study and no further action was planned.

Comment?

Related Topix: Biotech, Medicine, AstraZeneca Group, Healthcare Industry, Financial Markets, Business News

Mon Aug 18, 2014

AmericanBankingNews.com

Recent Analysts' Ratings Updates for AstraZeneca plc

A number of stock research firms have changed their ratings and price targets for AstraZeneca plc during the last seven days: AstraZeneca plc had its "underweight" rating reaffirmed by analysts at JPMorgan Chase & Co..

Comment?

Related Topix: Biotech, Medicine, AstraZeneca Group, Healthcare Industry, Banking, JP Morgan Chase

Sun Aug 17, 2014

Seeking Alpha

2nd Half Of 2014 Biotechnology Catalysts--Part 4

Through knowing when PDUFA decisions are going to be made, investors can benefit from the increased momentum and share price heading into the decision.

Comment?

Related Topix: Startups, Nektar Therapeutics, Biotech, Medicine, AstraZeneca Group, Healthcare Industry

Thu Aug 14, 2014

Seeking Alpha

Why GlaxoSmithKline Is A Tempting Buy

By now, most investors know all the problems facing pharmaceutical giant GlaxoSmithKline .

Comment?

Related Topix: Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, Pfizer, AstraZeneca Group

Wed Aug 13, 2014

Wall Street Journal

AstraZeneca Gets Good Results From Gout Drug Trials

AstraZeneca PLC reported on Wednesday positive results from three combination Phase III clinical trials of treatments for patients with gout, an inflammatory arthritis.

Comment?

Related Topix: Biotech, Medicine, AstraZeneca Group, Health, Healthcare Industry, Gout

Fri Aug 08, 2014

AmericanBankingNews.com

Recent Investment Analysts' Ratings Updates for AstraZeneca plc

A number of stock research firms have changed their ratings and price targets for AstraZeneca plc during the last seven days: AstraZeneca plc had its "hold" rating reaffirmed by analysts at Jefferies Group.

Comment?

Related Topix: Biotech, Medicine, AstraZeneca Group, Healthcare Industry, Investment Banking, Financial Services, Jefferies Group, Investment Services

Thu Aug 07, 2014

Seeking Alpha

Nektar Therapeutics Harnesses The Power Of AstraZeneca To Move Movantik

Nektar, and Nektar shareholder excitement surrounding FDA approval of Movantik on the fast-approaching date of September 16th might only be exceeded by that of partner AstraZeneca.

Comment?

Related Topix: Biotech, Medicine, AstraZeneca Group, Healthcare Industry, Startups, Nektar Therapeutics, Health, Pain

Wed Aug 06, 2014

Business Journal

Shire stock slides as Obama administration targets tax inversion deals

Shire's stock closed down 6 percent Wednesday after the Obama administration, through the Treasury Department, said it was exploring ways to deter the growing numbers of tax inversion deals being used corporations seeking to lower their tax bills.

Comment?

Related Topix: US News, US Treasury, Ireland, World News, Pfizer, Biotech, Medicine, Healthcare Industry, AstraZeneca Group

Tue Aug 05, 2014

Seeking Alpha

AstraZeneca Has 30% Upside As A Takeover Candidate

Talks may resume as early as this month if AstraZeneca is interested, but are more likely to resume in November.

Comment?

Related Topix: Biotech, Medicine, AstraZeneca Group, Healthcare Industry, Pfizer, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals

Mon Aug 04, 2014

Seeking Alpha

Dynavax Offers Both Potential Long-Term And Short-Term Trade Potential

Dynavax Technologies warrants attention of investors who are seeking potential long-term gains coupled with short term trade possibilities.

Comment?

Related Topix: Startups, Dynavax Technologies, Infectious Diseases, Medicine, Biotech, GlaxoSmithKline, Healthcare Industry, AstraZeneca Group

BioSpace

Hedge Funds Bet AstraZeneca PLC Will Stay Independent For A Little While Longer

The city's hedge fund community is betting that AstraZeneca will stay independent for a little while longer as enthusiasm for an imminent Pfizer takeover dampens.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, AstraZeneca Group

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••